Nicaragua calls Donald Trump's 'shithole' comments racist and disrespectful
Nicaragua on Monday joined the international chorus of criticism directed at US president Donald Trump over his reported slur against some poor nations.
Managua, Nicaragua: Nicaragua on Monday joined the international chorus of criticism directed at US president Donald Trump over his reported slur against some poor nations.
Trump's reported description of African state, Haiti and El Salvador as "shithole countries" in a meeting on migration was "racist... disrespectful and humiliating," the office of Nicaraguan President Daniel Ortega said in a statement.
The Nicaraguan presidency expressed solidarity with countries and regional organisations that have slammed the derogatory term.
Those sharply criticising Trump include Botswana, El Salvador, Ghana, Haiti, Nigeria, the 15-nation Caribbean Community, the African Union and the African Group of UN ambassadors.
Trump has responded to the outcry by telling reporters "I'm not a racist." He denied making the offensive remarks, despite two senators who attended the meeting confirming the accuracy of the news reports about the words Trump used.
Two other senators from Trump's ruling Republican Party called the reports a "gross misrepresentation" amid some accounts that the president might allegedly have used the word "shithouse" instead of "shithole."
Emotions are running high in El Salvador, Honduras and Nicaragua as Trump's administration moves to cancel temporary protection given to tens of thousands of their compatriots in the US.
Already more than 56 percent of American adults have received at least one dose of a COVID-19 vaccine and nearly 105 million are fully vaccinated
On behalf of the businesses, the American Immigration Council in March had filed a suit against the USCIS' arbitrary rejection of H-1B petitions filed after 1 October
The role of the Sackler family and their company, Purdue Pharma, in developing the prescription painkiller OxyContin is familiar territory. Gibney’s film digs into the aftermath, including the push to get doctors to overprescribe the medication and the company’s use of former government regulators to cripple serious oversight.